Vodafone Certified application status for the MedifyRemote™ application

vodafoneMedify Solutions Limited announced that it has been awarded Vodafone Certified application status for its MedifyRemote™ application. MedifyRemote™ is the first application of its type and allows healthcare professionals mobile access to review and update a patients' medical history records in a single, secure session via a standard Microsoft Windows Mobile PDA/phone device. The application offers no interference with the existing device functions, enabling one device to be utilised for telephone, email, calendar, internet access; as well patient note functions.

In order to achieve Vodafone Certified status, MedifyRemote™ underwent technical evaluation by Vodafone UK. As a result, the application has passed the approval process, meeting the high standards demanded by Vodafone UK's customer base and delivering value to the UK marketplace.

As a Certified application, Medify Solutions Limited now has access to Vodafone UK's technical expertise and will be recommended to appropriate customers by Vodafone UK account managers. MedifyRemote™ will be identified by the "Vodafone Certified Application" brand logo. This will allow Medify Solutions Limited to benefit from Vodafone UK's position as the UK's largest mobile network operator, offering its customers in-depth support and peace of mind when deploying new mobile applications.

Ian O'Reilly, CEO Medify Solutions Limited, said: "Gaining Vodafone Certified status represents a superb endorsement for the MedifyRemote™ application. Our mobile application is successfully leading the way in the UK NHS and the rapid development of the e-Healthcare sector. The recognition of the importance of MedifyRemote™ by a major organisation such as Vodafone UK, underlines the value that this application delivers to clinical users and partners alike. We are very much looking forward to continuing the strong partnership we have formed with Vodafone UK."

Nick Parbutt, Head of Enterprise Product, Vodafone UK said: "For many of our customers, mobile data applications, such as job scheduling or workforce management are a business imperative. Having experienced the business benefits that such applications deliver, these customers are now considering additional solutions to address day-to-day business requirements. Medify Solutions Limited has proven that it can address these needs and we look forward to working with its team to enable our customers to realise the efficiencies that MedifyRemote™ delivers."

MedifyRemote™ joins a number of other Certified application developers in the Vodafone UK applications portfolio which have developed solutions ranging from telematics and sales solutions to tools that replicate the functionality or content from the desktop environment on to the mobile device.

Those interested in further information should email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.medifysolutions.com

About the Medify Solutions
The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. For more information, please visit www.medifysolutions.com.

About Vodafone UK
Vodafone UK has 16.3 million customers and is part of the world’s leading international mobile telecommunications Group, offering a wide range of voice and data communications. The company is committed to providing mobile solutions that allow both consumer and business customers to make the most of now. In addition, Vodafone connects customers across the globe with roaming agreements worldwide. It provides 3G roaming in 29 countries and offers great roaming value with Vodafone Passport. For more information, please visit www.vodafone.co.uk.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...